The possible underlying pathophysiological mechanisms for development of multiple sclerosis in familial Mediterranean

Mahmut Alpayci1, Nazim Bozan, Seyfettin Erdem

  • 1Bitlis State Hospital, Physical Medicine and Rehabilitation Department, Bitlis, Turkey. mahmutalpayci@gmail.com

Medical Hypotheses
|March 13, 2012
PubMed

Insights

Familial Mediterranean fever (FMF) patients show increased risk for multiple sclerosis (MS). This is linked to pyrin mutations, inflammation, and blood-brain barrier issues, potentially exacerbated by FMF attacks.

Area of Science:

  • Neuroimmunology
  • Genetics
  • Rheumatology

Background:

  • Familial Mediterranean fever (FMF) is an autoinflammatory disorder.
  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • A potential genetic and pathophysiological link between FMF and MS is suggested by observed susceptibilities.

Purpose of the Study:

  • To propose underlying pathophysiological mechanisms connecting FMF and MS.
  • To explore the role of pyrin mutations and IL-1β in the co-occurrence of these diseases.
  • To investigate how FMF-related inflammation and endothelial dysfunction may contribute to MS pathogenesis.

Main Methods:

  • Review of existing literature on FMF and MS pathogenesis.
  • Analysis of the role of MEFV gene mutations (pyrin) and IL-1β.
  • Examination of FMF-associated factors like inflammation, endothelial dysfunction, and fever in relation to MS hallmarks (BBB disruption, demyelination, axonal damage).

Main Results:

  • Pyrin mutations, found more frequently in MS patients, are linked to increased IL-1β production, a key inflammatory mediator in MS.
  • FMF-related endothelial dysfunction and vasculitis may compromise the blood-brain barrier (BBB), initiating MS lesions.
  • High fever during FMF attacks can damage myelin and mitochondrial proteins, leading to demyelination, energy deficits, and axonal damage, all critical in MS.

Conclusions:

  • FMF patients may have a predisposition to MS due to shared inflammatory pathways involving pyrin and IL-1β.
  • Mechanisms include BBB disruption, demyelination, and mitochondrial dysfunction, potentially worsened by FMF activity and irregular colchicine use.
  • Further research is warranted to elucidate the precise relationship and therapeutic implications.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...